ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2019

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal-Bolus Therapy.

Jakob Langer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.